ID   NFAC4_RAT               Reviewed;         901 AA.
AC   D3Z9H7; A0A0G2K0L1;
DT   13-FEB-2019, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 1.
DT   27-MAR-2024, entry version 104.
DE   RecName: Full=Nuclear factor of activated T-cells, cytoplasmic 4;
DE            Short=NF-ATc4;
DE            Short=NFATc4;
DE   AltName: Full=T-cell transcription factor NFAT3;
DE            Short=NF-AT3 {ECO:0000303|PubMed:9568714};
GN   Name=Nfatc4; Synonyms=Nfat3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION.
RX   PubMed=9568714; DOI=10.1016/s0092-8674(00)81573-1;
RA   Molkentin J.D., Lu J.-R., Antos C.L., Markham B., Richardson J.,
RA   Robbins J., Grant S.R., Olson E.N.;
RT   "A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.";
RL   Cell 93:215-228(1998).
RN   [4]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=12370307; DOI=10.1128/mcb.22.21.7603-7613.2002;
RA   Wilkins B.J., De Windt L.J., Bueno O.F., Braz J.C., Glascock B.J.,
RA   Kimball T.F., Molkentin J.D.;
RT   "Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect
RT   in calcineurin-mediated cardiac hypertrophic growth.";
RL   Mol. Cell. Biol. 22:7603-7613(2002).
RN   [5]
RP   FUNCTION, AND UBIQUITINATION.
RX   PubMed=19026640; DOI=10.1016/j.febslet.2008.11.009;
RA   Fan Y., Xie P., Zhang T., Zhang H., Gu D., She M., Li H.;
RT   "Regulation of the stability and transcriptional activity of NFATc4 by
RT   ubiquitination.";
RL   FEBS Lett. 582:4008-4014(2008).
RN   [6]
RP   FUNCTION.
RX   PubMed=19538478; DOI=10.1111/j.1582-4934.2009.00804.x;
RA   Manukyan I., Galatioto J., Mascareno E., Bhaduri S., Siddiqui M.A.;
RT   "Cross-talk between calcineurin/NFAT and Jak/STAT signalling induces
RT   cardioprotective alphaB-crystallin gene expression in response to
RT   hypertrophic stimuli.";
RL   J. Cell. Mol. Med. 14:1707-1716(2010).
CC   -!- FUNCTION: Ca(2+)-regulated transcription factor that is involved in
CC       several processes, including the development and function of the
CC       immune, cardiovascular, musculoskeletal, and nervous systems. Involved
CC       in T-cell activation, stimulating the transcription of cytokine genes,
CC       including that of IL2 and IL4 (PubMed:12370307). Along with NFATC3,
CC       involved in embryonic heart development. Following JAK/STAT signaling
CC       activation and as part of a complex with NFATC3 and STAT3, binds to the
CC       alpha-beta E4 promoter region of CRYAB and activates transcription in
CC       cardiomyocytes (PubMed:19538478). Involved in mitochondrial energy
CC       metabolism required for cardiac morphogenesis and function.
CC       Transactivates many genes involved in heart physiology. Along with
CC       GATA4, binds to and activates NPPB/BNP promoter (PubMed:9568714).
CC       Activates NPPA/ANP/ANF and MYH7/beta-MHC transcription
CC       (PubMed:19026640). Binds to and transactivates AGTR2 gene promoter.
CC       Involved in the regulation of adult hippocampal neurogenesis. Involved
CC       in BDNF-driven pro-survival signaling in hippocampal adult-born
CC       neurons. Involved in the formation of long-term spatial memory and
CC       long-term potentiation. In cochlear nucleus neurons, may play a role in
CC       deafferentation-induced apoptosis during a developmental critical
CC       period when auditory neurons depend on afferent input for survival (By
CC       similarity). Binds to and activates the BACE1/Beta-secretase 1
CC       promoter, hence may regulate the proteolytic processing of the amyloid
CC       precursor protein (APP). Plays a role in adipocyte differentiation. May
CC       be involved in myoblast differentiation into myotubes (By similarity).
CC       Binds the consensus DNA sequence 5'-GGAAAAT-3' (By similarity). In the
CC       presence of CREBBP, activates TNF transcription. Binds to PPARG gene
CC       promoter and regulates its activity (By similarity). Binds to PPARG and
CC       REG3G gene promoters (By similarity). {ECO:0000250|UniProtKB:Q14934,
CC       ECO:0000250|UniProtKB:Q8K120, ECO:0000269|PubMed:12370307,
CC       ECO:0000269|PubMed:19026640, ECO:0000269|PubMed:19538478,
CC       ECO:0000269|PubMed:9568714}.
CC   -!- SUBUNIT: Member of the multicomponent NFATC transcription complex that
CC       consists of at least two components, a pre-existing cytoplasmic
CC       component NFATC2 and an inducible nuclear component NFATC1. Other NFAT
CC       proteins, such as NFATC4, NFATC3, or members of the activating protein-
CC       1 (AP-1) family and MAF can also bind the complex. NFAT proteins can
CC       bind DNA as monomers or dimers. Component of a promoter-binding complex
CC       composed of STAT3, NFATC3 and NFATC4; complex formation is enhanced by
CC       calcineurin (By similarity). Interacts with CREBBP; this interaction
CC       potentiates transcription activation (By similarity). Interacts with
CC       MAPK8/JNK1 and MAPK9/JNK2 (By similarity). Interacts with GATA4 (via
CC       the second Zn finger) (By similarity). Interacts (via N-terminus) with
CC       IRAK1 (via C-terminus). Interacts with RPS6KA3. Interacts with HOMER1,
CC       HOMER2 and HOMER3; this interaction competes with calcineurin/PPP3CA-
CC       binding and hence prevents NFATC4 dephosphorylation and activation (By
CC       similarity). Interacts with ESR1 and ESR2; this interaction decreases
CC       NFATC4 transcriptional activity. Interacts with MTOR and MAPK7/ERK5 (By
CC       similarity). Interacts with TRIM17; this interaction prevents NFATC3
CC       nuclear localization (By similarity). {ECO:0000250|UniProtKB:Q14934,
CC       ECO:0000250|UniProtKB:Q8K120}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q8K120}. Nucleus
CC       {ECO:0000250|UniProtKB:Q8K120}. Note=When hyperphosphorylated,
CC       localizes in the cytosol. When intracellular Ca(2+) levels increase,
CC       dephosphorylation by calcineurin/PPP3CA leads to translocation into the
CC       nucleus. MAPK7/ERK5 and MTOR regulate NFATC4 nuclear export through
CC       phosphorylation at Ser-168 and Ser-170. {ECO:0000250|UniProtKB:Q14934}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=D3Z9H7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=D3Z9H7-2; Sequence=VSP_060060, VSP_060061;
CC   -!- TISSUE SPECIFICITY: Expressed in heart (at protein level).
CC       {ECO:0000269|PubMed:12370307}.
CC   -!- DOMAIN: Rel similarity domain (RSD) or Rel homology domain (RHD) allows
CC       DNA-binding and cooperative interactions with AP-1 factors.
CC       {ECO:0000250|UniProtKB:O95644}.
CC   -!- PTM: Phosphorylated by NFATC-kinases; dephosphorylated by
CC       calcineurin/PPP3CA. Phosphorylated on Ser-168 and Ser-170 by MTOR,
CC       IRAK1, MAPK7/ERK5 and MAPK14/p38, on Ser-213 and Ser-217 by MAPK8 and
CC       MAPK9, and on Ser-289 and Ser-344 by RPS6KA3 (By similarity).
CC       Phosphorylated by GSK3B; this phosphorylation markedly increases NFATC4
CC       ubiquitination (PubMed:19026640). Phosphorylation by MAPK8/JNK1,
CC       MAPK9/JNK2 and RPS6KA3 may stimulate NFATC4 transcriptional activity.
CC       Phosphorylation at Ser-168 and Ser-170 is stimulated by UV irradiation
CC       (By similarity). {ECO:0000250|UniProtKB:Q14934,
CC       ECO:0000250|UniProtKB:Q8K120, ECO:0000269|PubMed:19026640}.
CC   -!- PTM: Ubiquitinated, leading to degradation by the proteasome.
CC       Ubiquitination may be stimulated by GSK3B-dependent phosphorylation.
CC       Polyubiquitin linkage mainly occurs through 'Lys-48'.
CC       {ECO:0000269|PubMed:19026640}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC116083; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH474049; EDM14287.1; -; Genomic_DNA.
DR   RefSeq; NP_001100734.1; NM_001107264.1. [D3Z9H7-1]
DR   AlphaFoldDB; D3Z9H7; -.
DR   SMR; D3Z9H7; -.
DR   STRING; 10116.ENSRNOP00000027789; -.
DR   iPTMnet; D3Z9H7; -.
DR   PhosphoSitePlus; D3Z9H7; -.
DR   PaxDb; 10116-ENSRNOP00000027789; -.
DR   PeptideAtlas; D3Z9H7; -.
DR   Ensembl; ENSRNOT00000027789.6; ENSRNOP00000027789.4; ENSRNOG00000020482.8. [D3Z9H7-1]
DR   Ensembl; ENSRNOT00000089584.2; ENSRNOP00000071490.1; ENSRNOG00000020482.8. [D3Z9H7-2]
DR   Ensembl; ENSRNOT00055020325; ENSRNOP00055016384; ENSRNOG00055011949. [D3Z9H7-1]
DR   Ensembl; ENSRNOT00060038839; ENSRNOP00060032091; ENSRNOG00060022398. [D3Z9H7-1]
DR   Ensembl; ENSRNOT00065050811; ENSRNOP00065041763; ENSRNOG00065029425. [D3Z9H7-1]
DR   GeneID; 305897; -.
DR   KEGG; rno:305897; -.
DR   AGR; RGD:1310749; -.
DR   CTD; 4776; -.
DR   RGD; 1310749; Nfatc4.
DR   eggNOG; ENOG502RIHQ; Eukaryota.
DR   GeneTree; ENSGT00940000160923; -.
DR   HOGENOM; CLU_010185_2_0_1; -.
DR   InParanoid; D3Z9H7; -.
DR   OMA; NMTAIDC; -.
DR   OrthoDB; 5405363at2759; -.
DR   TreeFam; TF326480; -.
DR   PRO; PR:D3Z9H7; -.
DR   Proteomes; UP000002494; Chromosome 15.
DR   Proteomes; UP000234681; Chromosome 15.
DR   Bgee; ENSRNOG00000020482; Expressed in pancreas and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0016607; C:nuclear speck; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IMP:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0042975; F:peroxisome proliferator activated receptor binding; IPI:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISS:UniProtKB.
DR   GO; GO:0031547; P:brain-derived neurotrophic factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; ISO:RGD.
DR   GO; GO:0033173; P:calcineurin-NFAT signaling cascade; ISO:RGD.
DR   GO; GO:0045333; P:cellular respiration; ISO:RGD.
DR   GO; GO:0071285; P:cellular response to lithium ion; ISO:RGD.
DR   GO; GO:0034644; P:cellular response to UV; ISO:RGD.
DR   GO; GO:0048813; P:dendrite morphogenesis; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; ISO:RGD.
DR   GO; GO:0007616; P:long-term memory; ISO:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0050774; P:negative regulation of dendrite morphogenesis; ISO:RGD.
DR   GO; GO:1902894; P:negative regulation of miRNA transcription; ISO:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:2000297; P:negative regulation of synapse maturation; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0030178; P:negative regulation of Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; ISO:RGD.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; IMP:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0060074; P:synapse maturation; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0097084; P:vascular associated smooth muscle cell development; ISO:RGD.
DR   GO; GO:0035886; P:vascular associated smooth muscle cell differentiation; ISO:RGD.
DR   CDD; cd01178; IPT_NFAT; 1.
DR   CDD; cd07881; RHD-n_NFAT; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   Gene3D; 2.60.40.340; Rel homology domain (RHD), DNA-binding domain; 1.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR002909; IPT_dom.
DR   InterPro; IPR008366; NFAT.
DR   InterPro; IPR008967; p53-like_TF_DNA-bd_sf.
DR   InterPro; IPR032397; RHD_dimer.
DR   InterPro; IPR011539; RHD_DNA_bind_dom.
DR   InterPro; IPR037059; RHD_DNA_bind_dom_sf.
DR   PANTHER; PTHR12533; NFAT; 1.
DR   PANTHER; PTHR12533:SF11; NUCLEAR FACTOR OF ACTIVATED T-CELLS, CYTOPLASMIC 4; 1.
DR   Pfam; PF16179; RHD_dimer; 1.
DR   Pfam; PF00554; RHD_DNA_bind; 1.
DR   PRINTS; PR01789; NUCFACTORATC.
DR   SMART; SM00429; IPT; 1.
DR   SUPFAM; SSF81296; E set domains; 1.
DR   SUPFAM; SSF49417; p53-like transcription factors; 1.
DR   PROSITE; PS50254; REL_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Cytoplasm; Developmental protein;
KW   Differentiation; DNA-binding; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..901
FT                   /note="Nuclear factor of activated T-cells, cytoplasmic 4"
FT                   /id="PRO_0000446288"
FT   REPEAT          213..229
FT                   /note="SP 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          277..293
FT                   /note="SP 2; approximate"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          401..582
FT                   /note="RHD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00265"
FT   DOMAIN          586..683
FT                   /note="IPT/TIG"
FT                   /evidence="ECO:0000255"
FT   DNA_BIND        430..437
FT                   /evidence="ECO:0000250|UniProtKB:Q14934"
FT   REGION          1..180
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          114..119
FT                   /note="Calcineurin-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q14934"
FT   REGION          203..361
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          213..293
FT                   /note="2 approximate SP repeats"
FT                   /evidence="ECO:0000255"
FT   REGION          697..721
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          791..868
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           268..270
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   MOTIF           672..674
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        57..85
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        269..285
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        293..308
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        326..340
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        803..823
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         168
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K120"
FT   MOD_RES         170
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K120"
FT   MOD_RES         213
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14934"
FT   MOD_RES         217
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14934"
FT   MOD_RES         289
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K120"
FT   MOD_RES         334
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14934"
FT   MOD_RES         344
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14934"
FT   CROSSLNK        689
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14934"
FT   VAR_SEQ         880..890
FT                   /note="VSEIIGRDLSG -> GGCGTGGCECE (in isoform 2)"
FT                   /id="VSP_060060"
FT   VAR_SEQ         891..901
FT                   /note="Missing (in isoform 2)"
FT                   /id="VSP_060061"
SQ   SEQUENCE   901 AA;  95764 MW;  97EBE1022C88D2A5 CRC64;
     MGAASCEDEE LEFKLVFGEE KEAPPLGPGG PGEELDSEDA PPCCRLALGE PLPYGAAPIG
     IPRPPPPRPG MHSPPPRPAP SPGTWESQPP RSVRLGGPGG TAGGTGGGRV LECPSIRITS
     ISPTPDPPTS LEDAPETWGD GSPRDYPPPE GFGGYREAGG QGGGAFFSPS PGSSSLSSWS
     FFSDASDEAA LYAACDEVES ELNEAASRFG LSSPLPSPRA SPRPWTPEDP WSLYGPSSGG
     RAPEDSWLLL SAPGPIPASP RPASPCGKRR YSSSGTPSSA SPALSRRGSL GEEGPEPPPP
     PPLPLVRDPS SSGPFDYVGA PPTESVPQKT RRTSSEQAVA LPRSEEPASC NGKLPSGTED
     SVAAPGALRK EMAGMDYLAV PSPLAWSKAR IGGHSPIFRT SALPPLDWPL PSQYEQLELR
     IEVQPRAHHR AHYETEGSRG AVKAAPGGHP VVKLLGYNEK PLTLQMFIGT ADERSLRPHA
     FYQVHRITGK MVATASYEAV VSGTKVLEMT LLPENNMAAN IDCAGILKLR NSDIELRKGE
     TDIGRKNTRV RLVFRVHVPQ GGGKVVSVQA ASVPIECSQR SAQELPQVEA YSPSACSVRG
     GEELVLTGSN FLPDSKVVFI ERGPDGKLQW EEEAAVNRLQ SSEVTLTLTI PEYSNKRVSR
     PVQVYFYVSN GRRKRSPTQS FKFLPVIFKE EPLPDSSLRG FPSTSGPPFG PDMDFSPPRP
     PYPSYPHEDP AYETPYLSEG FGYSTPALYP QTGPPPSYRS GLRMFPETGG TTGCARLPSV
     SFLPRPFPGD QYGGQGSSFP LGLPFSPPAP FRPPLPSSPP LEDPFNPQSA VHPLPAEGYN
     EVGPGYTPGE GASEQEKSRG GYGSGFRDNV PIQGITLEEV SEIIGRDLSG FPARPGEEPP
     A
//
